BCL2 and cancer: However, dysregulation of apoptosis owing to imbalanced Bcl-2 family members, downregulation of caspases, overexpression of inhibitors of apoptosis proteins (IAPs) or impairment of death-receptor signalling is a common phenomenon exhibited in various cancers including NSCLC.